VeriChip Corporation Supports Legislation Banning Forced Microchip Implantation
06 7월 2009 - 9:30PM
Business Wire
VeriChip Corporation (�VeriChip� or the �Company�)
(NASDAQ:CHIP), a provider of radio frequency identification (RFID)
systems for healthcare and patient-related needs, announced today
it supports Pennsylvania�s House of Representatives� recent passage
of a bill banning the forced implantation of microchips in
humans.
VeriChip�s VeriMed� Health Link patient identification system,
which utilizes an implantable RFID microchip in combination with a
handheld RFID scanner and a secure patient database, provides
immediate access to important identification and health information
for patients who arrive at an emergency department unable to
communicate. The VeriMed Health Link system was cleared by the FDA
in 2004 as a Class II medical device and is the first and only
implantable microchip cleared by the FDA for patient
identification.
Commenting on the legislation, Scott R. Silverman, Chairman of
VeriChip, said, �For years, we, as a Company, have enforced a
strict privacy policy that starts with the voluntary use of our
VeriMed Health Link patient identification system, which includes
our implantable microchip, the VeriChip. The primary application of
our VeriMed Health Link patient identification system and the
VeriChip microchip is to identify high-risk patients and their
medical records in an emergency or clinical situation.�
Continued Silverman, �In general, we are supportive of
legislation that prohibits forced implants. VeriChip, like any
other medical device, should be an election by the patient or his
or her physician, loved one or guardian. As long as legislators
understand the primary application of VeriChip and the benefits it
can provide, we support � in fact we started � the voluntary nature
of implantable RFID.�
On Monday, July 6, 2009, VeriChip will issue an additional
release explaining in detail the evolution of its VeriMed Health
Link patient identification system, and its current and future
applications.
About VeriChip
VeriChip Corporation, headquartered in Delray Beach, Florida,
has developed the VeriMed� Health Link System for rapidly and
accurately identifying people who arrive in an emergency room and
are unable to communicate. This system uses the first
human-implantable passive RFID microchip, cleared for medical use
in October 2004 by the United States Food and Drug Administration.
To complement its healthcare division, VeriChip Corporation
established VeriGreen Energy Corporation in March 2009 to focus and
invest in the clean and alternative energy sector.
For more information on VeriChip, please call 1-800-970-2447, or
e-mail info@verichipcorp.com. Additional information can be found
online at www.verichipcorp.com.
Statements about VeriChip�s future expectations, including
future revenues and earnings from the sale of its VeriMed Health
Link patient identification system, and all other statements in
this press release other than historical facts are �forward-looking
statements� within the meaning of Section 27A of the Securities Act
of 1933, Section 21E of the Securities Exchange Act of 1934, and as
that term is defined in the Private Litigation Reform Act of 1995.
Such forward-looking statements involve risks and uncertainties and
are subject to change at any time, and VeriChip�s actual results
could differ materially from expected results. Additional
information about these and other factors that could affect the
Company�s business is set forth in the Company�s various filings
with the Securities and Exchange Commission, including those set
forth in the Company�s 10-K filed on February 12, 2009, under the
caption �Risk Factors.� The Company undertakes no obligation to
update or release any revisions to these forward-looking statements
to reflect events or circumstances after the date of this statement
or to reflect the occurrence of unanticipated events, except as
required by law.
Verichip (MM) (NASDAQ:CHIP)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Verichip (MM) (NASDAQ:CHIP)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024
